DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay
Bitget2026/10/12 10:00- DataMeds AI’s Helomics unit secured Medicaid coverage under Humana policy for its ChemoFx chemoresponse assay in gynecologic cancers.
- Coverage took effect July 22, 2026 under Humana policy HUM-SC-2240-003, billed under CPT codes 81535 and 81536.
- Eligibility centers on select clinical scenarios, including recurrence or treatment-refractory disease, supporting potential volume growth for Helomics’ CLIA lab.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
